Moderna
MRNA
#1795
Rank
C$15.28 B
Marketcap
C$39.12
Share price
0.97%
Change (1 day)
-39.43%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -C$4.45 Billion

According to Moderna 's latest financial reports the company's current earnings are C$2.20 Billion. In 2024 the company made an earning of -C$4.97 Billion, an increase over its 2023 earnings that were of -C$5.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$4.45 Billion-10.38%
2024 -C$4.97 Billion-8.22%
2023 -C$5.41 Billion-140.65%
2022 C$13.30 B-27.81%
2021 C$18.42 B-1911.15%
2020 -C$1.02 Billion44.7%
2019 -C$0.71 Billion28.63%
2018 -C$0.55 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-C$65.71 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.98 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.86 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.18 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.74 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-C$0.11 Billion-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.87 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA